Hero banner - MSCI Immuno-oncology Index
MSCI Immuno-oncology Index
Social Sharing
content - MSCI Immuno-oncology Index
What is the MSCI ACWI Investable Market Immuno-oncology Index?
The MSCI ACWI IMI Immuno-oncology Index aims to represent the performance of a set of companies that are associated with research, development, and commercialization of products for cancer immunotherapy, also known as Immuno-oncology. Immuno-oncology is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control and eliminate cancer.
Video - MSCI ACWI IMI Immuno-oncology Index
MSCI ACWI IMI Immuno-oncology Index
It can be utilized by institutional investors for investment universe identification, internal research, and benchmarking; by product creators as the basis of ETF’s and structured products; and asset managers looking to identify potential investment opportunities.
MSCI Immuno-oncology Index - related content
Related content
The Forefront of Innovation: Vaccines and Antivirals
Since the start of the global pandemic, the development of novel vaccines and antiviral treatments has accelerated significantly.
Learn moreWhy Genomics is Poised for Growth
Genomics is paving the way for transformative solutions in healthcare, with the potential for considerable growth.
Read moredatonomy™
Developed in partnership with Goldman Sachs and Coin Metrics, datonomy creates a common set of metrics and characteristics, enabling investors to analyze digital assets in a consistent way.
Explore more